Please login to the form below

Not currently logged in
Email:
Password:

vericiguat

This page shows the latest vericiguat news and features for those working in and with pharma, biotech and healthcare.

Bayer taps Sensyne Health AI and real world data for cardiovascular research

Bayer taps Sensyne Health AI and real world data for cardiovascular research

Bayer has two cardiovascular disease candidates in its late-stage pipeline: neladenoson bialanate and vericiguat, both being developed for heart failure. .

Latest news

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics